Translate

Friday, December 6, 2019

thumbnail

FBIO Fortress Biotech, Inc. gains 38% Dec 6, 2019

Coronado Biosciences, Inc., a biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. Its principal pharmaceutical product candidates in clinical development include Trichuris suis ova or...http://www.priceseries.com/trade/FBIO-Fortress-Biotech-Inc-stock-gains-38-percent-a-Trade-Record-by-priceSeries-2019110820191206.html

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

TradeVisor Product Review

Review I II III IV

Blog Archive